Key facts
- Doctours Health’s last known valuation is $1.8M (Apr 2025).
- It has raised $130K; the latest was Early Stage VC in Nov 2025.
- Notable investors include Draper Associates, gBETA, LAUNCH Fund, Brimstone Hill Capital, Halogen Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Doctours Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Doctours Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Doctours Health
Operator of a medical tourism marketplace intended to connect individuals with international clinics for hair transplant services. The company's platform offers surgical and non-surgical hair restoration options such as follicular unit transplantation, follicular unit extraction (FUE), and robotic FUE, enabling patients to compare clinics, review services, and book consultations, all while facilitating access to affordable, FDA-approved treatments.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 5
- Website
- doctours.com/
- Ownership
- Privately Held (backing)
Doctours Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Doctours Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Doctours Health in its N-PORT filings yet. We sweep new filings monthly.